6,15-diketo-13,14-dihydroprostaglandin f1alpha has been researched along with nafazatrom in 1 studies
Studies (6,15-diketo-13,14-dihydroprostaglandin f1alpha) | Trials (6,15-diketo-13,14-dihydroprostaglandin f1alpha) | Recent Studies (post-2010) (6,15-diketo-13,14-dihydroprostaglandin f1alpha) | Studies (nafazatrom) | Trials (nafazatrom) | Recent Studies (post-2010) (nafazatrom) |
---|---|---|---|---|---|
11 | 0 | 0 | 92 | 5 | 0 |
Protein | Taxonomy | 6,15-diketo-13,14-dihydroprostaglandin f1alpha (IC50) | nafazatrom (IC50) |
---|---|---|---|
Polyunsaturated fatty acid 5-lipoxygenase | Rattus norvegicus (Norway rat) | 6.1667 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Myatt, L; Williams, HJ; Young, KD | 1 |
1 other study(ies) available for 6,15-diketo-13,14-dihydroprostaglandin f1alpha and nafazatrom
Article | Year |
---|---|
Thrombotic thrombocytopenic purpura: treatment with nafazatrom.
Topics: 6-Ketoprostaglandin F1 alpha; Adolescent; Epoprostenol; Female; Humans; Purpura, Thrombotic Thrombocytopenic; Pyrazoles; Pyrazolones | 1984 |